These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6139345)

  • 1. Multiplicity of arrhythmogenic factors. A plea for combined therapies.
    Coumel P
    Int J Cardiol; 1983; 4(4):477-80. PubMed ID: 6139345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: Combined administration of digitalis, quinidine and beta adrenergic blocking drugs in a refractory case of supra-ventricular arrhythmia].
    Kaburagi T; Kawamura O
    Jpn Circ J; 1975 Apr; 39(4):511-2. PubMed ID: 235661
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Nov; 90(5):665-75. PubMed ID: 242208
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined amiodarone and quinidine treatment in refractory tachyarrhythmias; clinical observation and experimental electrophysiologic study].
    Tao GS; Zhao CY; Wang XS
    Zhonghua Nei Ke Za Zhi; 1986 Jun; 25(6):335-7, 380-1. PubMed ID: 3757620
    [No Abstract]   [Full Text] [Related]  

  • 5. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical cardiology. Use of anti-arrhythmic agents other than digitalis.
    Dreifus LS
    J Kans Med Soc; 1970 Jul; 71(7):276-8. PubMed ID: 4393787
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe treatment of resistant ventricular arrhythmias with a combination of amiodarone and quinidine or mexiletine.
    Hoffmann A; Follath F; Burckhardt D
    Lancet; 1983 Mar; 1(8326 Pt 1):704-5. PubMed ID: 6132058
    [No Abstract]   [Full Text] [Related]  

  • 9. Acebutolol in cardiac arrhythmias.
    Lewis BS; Mitha AS; Gotsman MS
    S Afr Med J; 1974 Apr; 48(19):821-4. PubMed ID: 4150954
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1972 Oct; 27(20):875-81. PubMed ID: 4405247
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative characteristics of various anti-arrhythmia agents used under clinical conditions].
    Zamotaev IP; Loziskiĭ LG; Sandomirskiĭ BL; Venediktova MG
    Kardiologiia; 1978 Oct; 18(10):30-7. PubMed ID: 30853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacy.
    Duff HJ; Mitchell LB; Wyse DG; Gillis AM; Sheldon RS
    Clin Invest Med; 1991 Oct; 14(5):476-83. PubMed ID: 1660369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comment on combined use of beta-adrenergic stimulants and beta-adrenoblockers].
    Shvela Kh; Oltmanis G
    Kardiologiia; 1990 Sep; 30(9):90. PubMed ID: 1980326
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of arrhythmogenic effects of quinidine, digoxin and finoptin combination].
    Nesterov IuI; Kostin VI; Raevskaia LG; Kirikova LT
    Klin Med (Mosk); 1995; 73(4):86-7. PubMed ID: 7474836
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quinidine interactions with propranolol, phenytoin, verapamil and procainamide].
    Halawa B
    Pol Tyg Lek; 1984 Jun; 39(24):823-6. PubMed ID: 6494041
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of rhythm and conduction disorders].
    Chazov EI
    Kardiologiia; 1975 Jan; 15(1):5-10. PubMed ID: 235036
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacokinetics and pharmacodynamics of quinidine].
    Kholodov LE; Glezer MG; Makharadze RV
    Kardiologiia; 1983 Aug; 23(8):107-14. PubMed ID: 6353039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.